- Home
- TURN vs ANEB Comparison
TURN vs ANEB Comparison
Compare TURN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- ANEB
- Stock Information
- Founded
- TURN 1981
- ANEB 2020
- Country
- TURN United States
- ANEB United States
- Employees
- TURN N/A
- ANEB N/A
- Industry
- TURN Finance/Investors Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- ANEB Health Care
- Exchange
- TURN Nasdaq
- ANEB Nasdaq
- Market Cap
- TURN 46.3M
- ANEB 90.4M
- IPO Year
- TURN N/A
- ANEB 2021
- Fundamental
- Price
- TURN $4.96
- ANEB $2.37
- Analyst Decision
- TURN
- ANEB Buy
- Analyst Count
- TURN 0
- ANEB 2
- Target Price
- TURN N/A
- ANEB $8.00
- AVG Volume (30 Days)
- TURN 30.3K
- ANEB 124.1K
- Earning Date
- TURN 02-26-2018
- ANEB 11-12-2025
- Dividend Yield
- TURN N/A
- ANEB N/A
- EPS Growth
- TURN N/A
- ANEB N/A
- EPS
- TURN 0.29
- ANEB N/A
- Revenue
- TURN $488,011.00
- ANEB N/A
- Revenue This Year
- TURN N/A
- ANEB N/A
- Revenue Next Year
- TURN N/A
- ANEB N/A
- P/E Ratio
- TURN $16.32
- ANEB N/A
- Revenue Growth
- TURN 277.43
- ANEB N/A
- 52 Week Low
- TURN $3.12
- ANEB $0.80
- 52 Week High
- TURN $5.00
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- TURN 67.09
- ANEB 50.03
- Support Level
- TURN $4.51
- ANEB $1.77
- Resistance Level
- TURN $4.90
- ANEB $2.26
- Average True Range (ATR)
- TURN 0.17
- ANEB 0.19
- MACD
- TURN -0.01
- ANEB -0.05
- Stochastic Oscillator
- TURN 90.00
- ANEB 53.10
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.